The
Ireland immunotherapy market is anticipated to witness an impressive growth during
the forecast period. This can be ascribed to the growing demand
for cancer treatment because it gives some health benefits such as tumor
reduction, improved survival rate, disease control and progression prevention,
palliative care, and symptoms relief along with growing demand for combination
therapy as cancer treatment health benefits. Also, increasing demand for personalized
medicine additives along with growing demand for combination therapy and
precision oncology such as chemotherapy, radiation and immunotherapy, hormonal,
and targeted therapy are expected to create a lucrative growth of Ireland immunotherapy
market during the forecast period. According to National Cancer Registry Ireland (NCRI),
age group of population suffering from Leukaemia 75+ years are 30%,65-74 years
24%, 50-64 years 23% and <50years 23% and Death records are 75+ years are
51%, 65-74 years 28%, 50-64 years 12% and <50 years 9%. Cancer treatments, such as immunotherapy, aim to
shrink or eliminate tumours. This can lead to disease remission, prolonged
survival, and potentially cure the cancer in some cases. Advances in cancer
treatments have contributed to increased survival rates for many types of
cancer. Early detection, combined with timely and effective treatment, can
significantly improve the chances of long-term survival contribute to the growth
of Ireland immunotherapy market.
Growing Prevalence of
Cancer Diseases
The rising incidence of
cancer in Ireland has created a higher demand for effective and targeted
treatments. Increase in prostate cancer is 114% with 6870 cases, 119% for lung
cancer with cases 5450 and 63% for female breast cancer to 5050 cases and 112%
for colon cancer to 3810 cases. Immunotherapy offers innovative treatment
options that harness the body's immune system to fight cancer cells. As
traditional treatment modalities may have limitations, such as resistance or
toxicity, immunotherapy provides a valuable alternative or complementary approach.
The growing prevalence of cancer has fueled the need for a diverse range of
treatment options. It is estimated that 44,000 peoples in Ireland get cancer
each year. Immunotherapy offers an additional therapeutic avenue that can
be used alone or in combination with other treatments like chemotherapy,
radiation therapy, or surgery. This expanded range of treatment options allows
healthcare providers to personalize treatment plans based on individual patient
characteristics and cancer types this may anticipated in the growth of Ireland immunotherapy
market. Immunotherapy has demonstrated promising results in improving outcomes
and survival rates for certain types of cancers.15-20% of patients achieve
durable results with immunotherapy. It has shown success in advanced or
metastatic cancers that may have limited treatment options. The potential to
extend survival and achieve durable responses drives the adoption of
immunotherapy in clinical practice. Immunotherapy aligns with the principles of
precision medicine by targeting specific biomarkers or molecular pathways in
individual patients. With advancements in genomic profiling and molecular
diagnostics, healthcare providers can identify patients who are more likely to
respond to immunotherapy. This targeted approach enhances treatment
effectiveness and reduces unnecessary treatment exposure for patients who may
not benefit from other therapies contributes to the growth of Ireland immunotherapy
market.
Rise in Geriatric
Population
Cancer incidence tends to be
higher among the elderly population. As people age, they are at a higher risk
of developing cancer due to cumulative exposure to various risk factors and a
weakened immune system. On an average 22,321 new cases of cancer are diagnosed
each year the almost all 3 quarters 74% of people who dies through cancer are
over the age of 65 years. The growing geriatric population in Ireland
directly translates to a higher prevalence of cancer, leading to an increased
demand for cancer treatments, including immunotherapy. Immunosenescence refers
to the natural age-related decline in immune function. Decreased maturation
of lymphocytes in secondary lymphoid organs and decreased B and T cell
production in the thymus and bone marrow.
Older individuals may have compromised immune responses, making
traditional cancer treatments like chemotherapy less effective or more
challenging to tolerate. Immunotherapy offers an alternative treatment approach
that harnesses the immune system to target cancer cells, regardless of
age-related immune changes. It provides a valuable option for elderly patients
who may have limited treatment options may go for immunotherapy this may
promotes the growth of Ireland Immunotherapy market. Advancements in healthcare
have led to increased life expectancy among the elderly population. As
individuals live longer, maintaining a good quality of life becomes paramount.
Immunotherapy, with its potential to achieve durable responses and prolonged
survival, contributes to enhancing the quality of life for elderly patients by
providing effective cancer control and management The rise in the geriatric
population drives the demand for Ireland immunotherapy market.
Growing Awareness for
Immunotherapy Among Consumers
Growing awareness for
immunotherapy among consumers plays a significant role in driving the Ireland
immunotherapy market as consumers become more aware of the potential benefits
and advancements in immunotherapy, there is a corresponding increase in the
demand for these treatments. Patients and their families actively seek out
information about immunotherapy as a viable option for cancer treatment,
leading to higher patient interest and demand because Immunotherapy can even
be continued during pregnancy because it is based on modified allergens rather
than drugs. Due to the extremely low possibility of an allergic reaction, the
initial dose is administered in Allergy Ireland under medical supervision. The
remaining part of the course of treatment is completed at home. Due to its
flexible treatment the Ireland immunotherapy market expected to grow. The
internet and digital platforms have made it easier for consumers to access
information about immunotherapy. Online resources, patient forums, social
media, and reputable healthcare websites provide educational materials, success
stories, and news about the latest developments in immunotherapy. In 2021,
93% of households have internet connections in Ireland an increase of 1% since
2020. This increased accessibility to information enhances consumer
awareness and understanding of the treatment. Media coverage of breakthroughs
and success stories related to immunotherapy generates public interest and
awareness. News articles, documentaries, and interviews with healthcare professionals
highlight the potential of immunotherapy in cancer treatment, leading to
increased consumer awareness. Irish Society of Medical Oncology (ISMO)
Annual Meeting or the Irish Association for Cancer Research (IACR) Conference,
often include sessions dedicated to immunotherapy as the growing awareness
also drives the Ireland immunotherapy market.
Download Free Sample Report
Recent Developments
In 2022, Novartis announced it had reached an agreement
with Sterling Pharma Solutions, a leading global development and manufacturing
company, to produce medicine for Novartis (active pharmaceutical ingredient
(API)) in Ireland. Sterling Pharma Solutions are producing Novartis APIs for
cardiology, immunology, and oncology medicines.
The production facilities
secured a USD 16 million investment from Novartis, to manufacture a significant
cardiovascular medicine on the site.
In
1981, this Janssen facility started
producing bulk active pharmaceutical components. These chemicals are then
export all over the world to be turned into pills, creams, or injectable
medications.
These have been significant developments in the
company's portfolio expansion strategy AstraZeneca has invested almost USD 40
billion on cardiovascular disease acquisitions over the past four years through
six deals. AstraZeneca has also participated in five deals related to oncology
and five deals related to respiratory diseases during this time.
In 2019-2020, Lilly has made 18 acquisitions and 58
investments Loxo Oncology acquire for USD 8 billion and IN 2020 acquire
Dermiria for USD 1.10 billion.
Market
Segmentation
The Ireland
immunotherapy market can be segmented by technology, indication, end user, and region.
Based on technology, the market can be segmented into monoclonal
antibodies, cytokines & immunomodulators, inhibitors, and others. Based on indication, the market can
be segmented into oncology, autoimmune diseases,
infectious diseases, and others. Based on end user, the market can be
grouped into hospitals & clinics, ambulatory care centers, research &
academic institutions, and others. Based on region, the market is segmented
into Dublin, Cork, Galway, and Limerick.
Market Players
Bristol Myers Squibb Co., Merck Sharp &
Dohme (MSD) Corp, Pfizer Inc, Roche AG, Eli Lilly & Co, AstraZeneca PLC,
Novartis AG, and Janssen Sciences Ireland UC are some of the leading players
operating in the Ireland immunotherapy market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic
Data
|
2018 – 2021
|
|
Estimated
Year
|
2023
|
|
Forecast
Period
|
2024 – 2028
|
|
Quantitative
Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
|
|
Report Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments Covered
|
Technology
Indication
End User
|
|
Regional Scope
|
Dublin,
Cork, Galway, and Limerick
|
|
Key Companies
Profiled
|
Bristol Myers Squibb Co., Merck Sharp & Dohme (MSD) Corp,
Pfizer Inc, Roche AG, Eli Lilly & Co, AstraZeneca PLC, Novartis AG,
Janssen Sciences Ireland UC
|
|
Customization
Scope
|
10% free
report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing and
Purchase Options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery
Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/Word format on special request)
|
Report
Scope:
In this report, the Ireland
immunotherapy market has been segmented into the following categories, in
addition to the industry trends which have also been detailed below:
- Ireland Immunotherapy Market, By Technology Type:
- Monoclonal
Antibodies
- Cytokines
& Immunomodulators
- Inhibitors
- Others
- Ireland Immunotherapy Market, By Indication:
- Oncology
- Autoimmune
Diseases
- Infectious
Diseases
- Others
- Ireland Immunotherapy Market, By End User:
- Hospitals
& Clinics
- Ambulatory
Care Centers
- Research
& Academic Institutions
- Others
- Ireland Immunotherapy Market, By Region:
- Dublin
- Cork
- Galway
- Limerick
Competitive
Landscape
Company
Profiles: Detailed analysis of the major companies present Ireland
immunotherapy market.
Available
Customizations:
With the given market
data, TechSci Research offers customizations according to a company’s specific
needs. The following customization options are available for the report:
Company
Information
Detailed analysis and
profiling of additional market players (up to five).
Ireland
immunotherapy market is an upcoming report to be released soon. If you wish an
early delivery of this report or want to confirm the date of release, please
contact us at [email protected]